Literature DB >> 10193317

Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies.

D Taylor-Robinson1, B J Thomas.   

Abstract

Mesh：

Year:  1998        PMID： 10193317      PMCID： PMC500968          DOI： 10.1136/jcp.51.11.793

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  35 in total

1.  Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis.

Authors:  L A Jackson; L A Campbell; R A Schmidt; C C Kuo; A L Cappuccio; M J Lee; J T Grayston
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

3.  Chlamydia pneumoniae infection and coronary heart disease. Trials should assess whether antibiotics eliminate organism from atherosclerotic lesions.

Authors:  D Taylor-Robinson
Journal:  BMJ       Date:  1997-12-06

4.  Can we treat coronary artery disease with antibiotics?

Authors:  G Y Lip; D G Beevers
Journal:  Lancet       Date:  1997-08-09       Impact factor: 79.321

5.  Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profile.

Authors:  M Maass; J Gieffers
Journal:  J Infect       Date:  1997-09       Impact factor: 6.072

Review 6.  Periodontal disease and cardiovascular disease.

Authors:  J Beck; R Garcia; G Heiss; P S Vokonas; S Offenbacher
Journal:  J Periodontol       Date:  1996-10       Impact factor: 6.993

7.  Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain.

Authors:  C C Kuo; A M Gown; E P Benditt; J T Grayston
Journal:  Arterioscler Thromb       Date:  1993-10

8.  Cytomegalovirus DNA in arterial walls of patients with atherosclerosis.

Authors:  J L Melnick; C Hu; J Burek; E Adam; M E DeBakey
Journal:  J Med Virol       Date:  1994-02       Impact factor: 2.327

9.  Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy.

Authors:  S M Weiss; P M Roblin; C A Gaydos; P Cummings; D L Patton; N Schulhoff; J Shani; R Frankel; K Penney; T C Quinn; M R Hammerschlag; J Schachter
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

10.  Viruses in the etiology of atherosclerosis.

Authors:  E P Benditt; T Barrett; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205
View more
  17 in total

1.  Chlamydia pneumoniae and atherosclerosis.

Authors:  Y Wong; M E Ward
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

2.  Relation of C pneumoniae antibodies to ischaemic heart disease. Why were samples weakly positive for IgG antibodies not tested for IgA antibodies?

Authors:  D Taylor-Robinson; B J Thomas
Journal:  BMJ       Date:  1999-12-11

3.  Is Mycoplasma pneumoniae associated with vascular disease?

Authors:  B Maraha; A van Der Zee; A M Bergmans; M Pan; M F Peeters; H F Berg; G J Scheffer; J A Kluytmans
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 4.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

5.  Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells.

Authors:  Robert E Molestina; Jon B Klein; Richard D Miller; William H Pierce; Julio A Ramirez; James T Summersgill
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

6.  Comments on the failure to detect Chlamydia pneumoniae in atherosclerosis.

Authors:  D Taylor-Robinson; J Boman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-23       Impact factor: 3.267

7.  Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge.

Authors:  J M Vuola; V Puurula; M Anttila; P H Mäkelä; N Rautonen
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

8.  The failure of antibiotics to prevent heart attacks.

Authors:  David Taylor-Robinson; Jens Boman
Journal:  BMJ       Date:  2005-08-13

9.  Distribution of Chlamydia pneumoniae DNA in atherosclerotic carotid arteries: significance for sampling procedures.

Authors:  Melanie Cochrane; Andreas Pospischil; Philip Walker; Harry Gibbs; Peter Timms
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

10.  Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial.

Authors:  Hans F Berg; Boulos Maraha; Anneke van der Zee; Siska K Gielis; Paul J M Roholl; Gert-Jan Scheffer; Marcel F Peeters; Jan A J W Kluytmans
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.